NAFLD is the most common cause of chronic liver disease in the United States, driven by factors such as obesity, metabolic syndrome, and diabetes.
The ACG guidelines recommend PPIs as the first-line treatment for GERD due to their superior efficacy in reducing stomach acid and managing symptoms compared to other treatment options.
The ACG recommends that average-risk individuals start screening for colorectal cancer at age 45. This is a shift from the previous recommendation of starting at age 50, reflecting updated data that shows an increase in colorectal cancer cases in younger populations.
Mesalamine (5-ASA) is typically used as a first-line treatment for inducing remission in patients with mild-to-moderate ulcerative colitis. It works by reducing inflammation in the lining of the colon.
Triple therapy with a PPI, amoxicillin, and clarithromycin is a commonly recommended first-line treatment for H. pylori eradication, especially in areas with low clarithromycin resistance. In regions with higher resistance, bismuth quadruple therapy may be preferred.
